Erbitux cetuximab regulatory update

The National Comprehensive Cancer Network (NCCN) added Erbitux cetuximab to the NCCN Drugs & Biologics Compendium listing for non-small cell lung cancer (NSCLC), which the Centers for Medicare and Med...